tirzepatide hfpef 𧬠New data from the SUMMIT trial reveals that long-term (Zepbound) may significantly improve kidney function in patients with obesity, chronic kidney disease (CKD), and heart failure with preserved ejection fraction ( Efficacy and safety of Tirzepatide
Description
Impaired motivation (e.g., in patients with anhedonia) is associated with a reduced quality of life and treatment resistance 85,86
Further, GLP-1 RAs were assessed as a class, which may obscure drug specific impact on cancer risk
The difference reflects both absorption efficiency and the weekly dosing advantage of injections, which maintain steadier hormone levels throughout treatment
This is standard for specialty medications and virtually universal for GLP-1 weight loss drugs regardless of insurer
10.1245/s10434-017-5982-4 74 McLaughlinS
